The H. Lee Moffitt Cancer Center & Research Institute opened in 1986 on the University of South Florida campus with the mission """"""""to contribute to the prevention and cure of cancer."""""""" The Cancer Center enjoys close ties at multiple levels of the University structure, and benefits from the clearly articulated authorities of the Center Director and the Center's independent financial status. Over the past five years, the Cancer Center has invested over $18 million in research programs, personnel and infrastructure. In addition, a $14 million renovation of the Research Center and other laboratories during the same time period expanded research space from 18,000 sf in 1993 to 90,000 sf currently. The commitment to research complements the strong clinical operation of the hospital, which admits 4,000 inpatients per year; the clinics, which has more than 80,000 patient visits in 1995-96; and the unique Lifetime Cancer Screening Center, which sees more than 7,000 healthy and high risk individuals each year. The Cancer Center's four established research program include Molecular Oncology, Immunology, Clinical Investigations and Cancer Control. The programs have built on the collective strengths of faculty from multiple departments and colleges and the excellence of a strong clinical care setting. The Cancer Center Support Grant will enable the Cancer Center to expand its research focus to include genetics, to be developed as a joint basic science and cancer control effort. Additionally, the CCSG will support expansion of shared resources to accommodate increased usage from growth in personnel and scope of research. Shared resources includes Flow Cytometry, Pathology, Molecular Biology, Glass Wash, Molecular Imaging, Biostatistics, Data Management, and an animal core in the Cancer Research Center which will add transgenic services in the coming year. Most importantly, the CCSG will provide focused support for enhanced development of translational research through support of senior leaders and program leaders in their roles as they work with cancer center members to promote laboratory-clinical-laboratory interactions and translations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA076292-03S1
Application #
6283379
Study Section
Subcommittee G - Education (NCI)
Project Start
1998-02-19
Project End
2001-01-31
Budget Start
2000-03-14
Budget End
2001-01-31
Support Year
3
Fiscal Year
2000
Total Cost
$86,198
Indirect Cost
Name
University of South Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Karolak, Aleksandra; Markov, Dmitry A; McCawley, Lisa J et al. (2018) Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues. J R Soc Interface 15:
Liu, Ying; Wang, Hua; Li, Qian et al. (2018) Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study. Radiology 286:298-306
Padron, Eric; Ball, Markus C; Teer, Jamie K et al. (2018) Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes. Blood 131:2402-2405
Verduzco, Daniel; Kuenzi, Brent M; Kinose, Fumi et al. (2018) Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines. Mol Cancer Ther 17:73-83
Lee, Morgan S; Tyson, Dinorah Martinez; Gonzalez, Brian D et al. (2018) Anxiety and depression in Spanish-speaking Latina cancer patients prior to starting chemotherapy. Psychooncology 27:333-338
Correa, John B; Brandon, Karen O; Meltzer, Lauren R et al. (2018) Electronic cigarette use among patients with cancer: Reasons for use, beliefs, and patient-provider communication. Psychooncology 27:1757-1764
Divakaran, Anand; Talluri, Siva K; Ayoub, Alex M et al. (2018) Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. J Med Chem 61:9316-9334
de Mingo Pulido, Álvaro; Gardner, Alycia; Hiebler, Shandi et al. (2018) TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. Cancer Cell 33:60-74.e6
Li, Gongbo; Boucher, Justin C; Kotani, Hiroshi et al. (2018) 4-1BB enhancement of CAR T function requires NF-?B and TRAFs. JCI Insight 3:
McIntyre, Jessica; Jiménez, Julio; Rivera, Yonaira M et al. (2018) Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. J Cancer Educ 33:833-841

Showing the most recent 10 out of 1254 publications